Acceptability of treatment of latent tuberculosis infection in newly HIV-infected young women in Uganda

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 12, 2010, Pages 1647-1649

  Bark, Charles M ^a   Morrison, C S ^b   Salata, R A ^a   Byamugisha, J K ^c   Katalemwa, N H ^d   Mugerwa, R D ^d   Mukasa, J B ^e   Musoke, R N ^d   Nankya Mutyoba, J ^f   Rwambuya, S ^a   Walker, C J ^a   Johnson, J L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RTI International   (United States)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^f MAKERERE UNIVERSITY   (Uganda)

Author keywords

Acceptability; AIDS; HIV; Isoniazid; Tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ATTITUDE TO ILLNESS; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UGANDA;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS; UGANDA; YOUNG ADULT;

EID: 78649388889     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
2. Munseri P J, Talbot E A, Mtei L, Fordham von Reyn C. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Int J Tuberc Lung Dis 2008; 12: 1037-1041.
3. Golub J E, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 2009; 23: 631-636.
4. Golub J E, Saraceni V, Cavalcante S C, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21: 1441-1448.
5. Morrison C S, Richardson B A, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21: 85-95.
6. Hiransuthikul N, Nelson K E, Hiransuthikul P, Vorayingyong A, Paewplot R. INH preventive therapy among adult HIV-infected patients in Thailand. Int J Tuberc Lung Dis 2005; 9: 270-275.
7. Mugisha B, Bock N, Mermin J, et al. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int J Tuberc Lung Dis 2006; 10: 761-767.
8. Lugada E S, Watera C, Nakiyingi J, et al. Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. Int J Tuberc Lung Dis 2002; 6: 326-331.